Blog

Jan 15, 2016

Genomics, Cannabidiols Drive Epilepsy Research

Posted by in categories: biotech/medical, genetics, neuroscience

This is excellent news for Epilepsy.


Epilepsy, a disorder in which nerve cell activity in the brain is disturbed, causing seizures, is the fourth most common neurological problem, following only migraine, stroke and Alzheimer’s. There is no cure for epilepsy, but there are a variety of treatment options. The disease is estimated to affect 2.2 million people in the U.S., with 150,000 people developing the condition each year.

Personalized medicine Scientists at AES discussed how new technologies, such as gene editing using CRISPR-Cas9, and next-generation sequencing, are empowering them to take a new crack at the human genome and find new ways to diagnose and treat epilepsy.

“Recent advances in DNA sequencing and genomic technologies has facilitated a flood of discoveries in identifying genetic causes of epilepsy. Where we’ve been most successful is in the epileptic encephalopathies (EE),” lead author of one of the studies presented, Candace Myers, a senior at the University of Washington, said in a press conference.

Read more

Comments are closed.